Latest
Universities in Germany and Sweden Lose Access to Elsevier Journals
Universities in Germany and Sweden Lose Access to Elsevier Journals
Diana Kwon | Jul 19, 2018
Consortia in both countries are pushing for open-access subscriptions with the publisher.
Two Fungal Species—One Pathogenic, One Benign—Are Actually the Same
Two Fungal Species—One Pathogenic, One Benign—Are Actually the Same
Sukanya Charuchandra | Jul 19, 2018
Under one name the species is used in food fermentation, and under the other it is a drug-resistant cause of yeast infections.
CRISPR Is Overcome When Viruses Gang Up on Bacteria
CRISPR Is Overcome When Viruses Gang Up on Bacteria
Kerry Grens | Jul 19, 2018
Phages that die during bacterial invasion help other viruses defeat the microbes’ immune responses.
German Scientists Frequently Publish in Predatory Journals
German Scientists Frequently Publish in Predatory Journals
Catherine Offord | Jul 19, 2018
At least 5,000 of the country’s researchers have published their work on questionable platforms, often forking over exorbitant fees, a report finds.
Trump Nominates Scott Hutchins for USDA Top Scientist
Trump Nominates Scott Hutchins for USDA Top Scientist
Sukanya Charuchandra | Jul 18, 2018
A pesticide industry leader, Hutchins was formerly president of the Entomological Society of America.
Proposed EPA “Transparency” Rule Criticized
Proposed EPA “Transparency” Rule Criticized
Shawna Williams | Jul 18, 2018
Opponents of the guidelines, which would bar results of many public health studies from use in policy making, include scientific and healthcare organizations.
Synthetic Botox Treats Chronic Pain in Mice
Synthetic Botox Treats Chronic Pain in Mice
Abby Olena | Jul 18, 2018
Researchers silence pain neurons in the mouse spinal cord with injections of botulinum toxins modified to bind to the neurons’ receptors.
Questions Raised About “Breakthrough” Therapies’ Clinical Support
Questions Raised About “Breakthrough” Therapies’ Clinical Support
Catherine Offord | Jul 17, 2018
Compared to other drugs, therapeutics given breakthrough status receive FDA approval on the basis of weaker trial evidence, a study finds.
Cancer Geneticist Quits After Harassment Allegations
Cancer Geneticist Quits After Harassment Allegations
Kerry Grens | Jul 17, 2018
Accusations that Nazneen Rahman bullied employees at the Institute of Cancer Research in the U.K. stretch back 12 years.